{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:53:13Z","timestamp":1761155593822},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T00:00:00Z","timestamp":1337126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Recent studies from Austria, France and Italy have shown that there is a poor adherence to the screening scheme for maternal <jats:italic>Toxoplasma<\/jats:italic> infections in pregnancy demonstrated by the fact that many recommended examinations are missed. This leads to undetected infections and limits our knowledge of incidence of the disease. We discuss the negative consequences of this situation on research on treatment effectiveness and the outcomes of congenital toxoplasmosis. The responsible public health institutions should assume responsibility for appropriate surveillance of the screening programme and take measures to improve screening adherence during pregnancy. Screening should start as early as possible in pregnancy and the latest test should be done at delivery. Screening schedule should allow distinguishing infections from the first, second and third trimester of pregnancy, as the risk of materno-foetal transmission and outcomes in case of foetal infections varies by time.<\/jats:p>","DOI":"10.1186\/1471-2334-12-118","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T14:01:35Z","timestamp":1337176895000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u201cBlind periods\u201d in screening for toxoplasmosis in pregnancy in Austria \u2013 a debate"],"prefix":"10.1186","volume":"12","author":[{"given":"Ulrich","family":"Sagel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael T","family":"Mikolajczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,16]]},"reference":[{"key":"1947_CR1","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/B0-72-160537-0\/50033-5","volume-title":"Infectious Diseases of the Fetus and the Newborn Infant","author":"JS Remington","year":"2006","unstructured":"Remington JS, McLeod R, Thulliez P, Desmonts G: Toxoplasmosis. Infectious Diseases of the Fetus and the Newborn Infant. Edited by: Remington JS, Klein JO, Wilson CB, Baker CJ. 2006, Elsevier Saunders, Philadelphia, 947-1091. 6","edition":"6"},{"issue":"15","key":"1947_CR2","doi-asserted-by":"crossref","first-page":"pii=18834","DOI":"10.2807\/ese.13.15.18834-en","volume":"13","author":"A B\u00e9nard","year":"2008","unstructured":"B\u00e9nard A, Petersen E, Salamon R, Ch\u00eane G, Gilbert R, Salmi LR, et al: The European Toxo Prevention Study Group: Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Eurosurveill. 2008, 13 (15): pii=18834-[cited 2010 Aug 7. http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=18834]","journal-title":"Eurosurveill"},{"key":"1947_CR3","volume-title":"National public health policies and routines programs to prevent congenital Toxoplasmosis [Unpublished report]. Bordeaux (France)","author":"V Leroy","year":"2005","unstructured":"Leroy V, Raeber P-A, Petersen E, The European Toxo Prevention Study Group: National public health policies and routines programs to prevent congenital Toxoplasmosis [Unpublished report]. Bordeaux (France). 2005, [cited 2010 Aug 7http:\/\/www.eurotoxo.isped.u-bordeaux2.fr]"},{"key":"1947_CR4","unstructured":"Asp\u00f6ck H, Pollak A: Prevention of Prenatal Toxoplasmosis by Serological Screening of Pregnant Women in Austria. Scand J Infect Dis. 1992, (Suppl84): 32-38."},{"key":"1947_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1586\/14787210.1.1.175","volume":"1","author":"E Petersen","year":"2003","unstructured":"Petersen E, Remmer Schmidt D: Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?. Expert Rev Anti-infect Ther. 2003, 1: 175-182. 10.1586\/14787210.1.1.175.","journal-title":"Expert Rev Anti-infect Ther"},{"key":"1947_CR6","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","volume":"39","author":"G Pappas","year":"2009","unstructured":"Pappas G, Roussos N, Falagas ME: Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009, 39: 1385-1394. 10.1016\/j.ijpara.2009.04.003.","journal-title":"Int J Parasitol"},{"key":"1947_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/BF02079067","volume":"154","author":"M Mombr\u00f2","year":"1995","unstructured":"Mombr\u00f2 M, Perathoner C, Leone A, et al: Congenital toxoplasmosis: 10-year follow up. Eur J Pediatr. 1995, 154: 635-639. 10.1007\/BF02079067.","journal-title":"Eur J Pediatr"},{"key":"1947_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0140-6736(07)60072-5","volume":"369","author":"R Thi\u00e9baut","year":"2007","unstructured":"Thi\u00e9baut R, Leproust S, Ch\u00eane G, Gilbert R, Systematic Review on Congenital Toxoplasmosis study group: Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients\u2019 data. Lancet. 2007, 369: 115-122.","journal-title":"Lancet"},{"key":"1947_CR9","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1080\/08035250500251999","volume":"94","author":"L Gras","year":"2005","unstructured":"Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M, European Multicentre Study on Congenital Toxoplasmosis study group, et al: Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr. 2005, 94: 1721-1731. 10.1080\/08035250500251999.","journal-title":"Acta Paediatr"},{"key":"1947_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1470-0328(02)02325-X","volume":"110","author":"R Gilbert","year":"2003","unstructured":"Gilbert R, Gras L, European Multicentre Study on Congenital Toxoplasmosis study group: Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. Br J Obstet Gynaecol. 2003, 110: 112-120.","journal-title":"Br J Obstet Gynaecol"},{"key":"1947_CR11","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/ije\/30.6.1303","volume":"30","author":"R Gilbert","year":"2001","unstructured":"Gilbert R, Gras L, Wallon M, Peyron F, Ades AE, Dunn DT: Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol. 2001, 30: 1303-1308. 10.1093\/ije\/30.6.1303.","journal-title":"Int J Epidemiol"},{"key":"1947_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/adc.2004.066514","volume":"91","author":"DR Schmidt","year":"2006","unstructured":"Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H, Petersen E: The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999\u20132003. Arch Dis Child. 2006, 91: 661-665. 10.1136\/adc.2004.066514.","journal-title":"Arch Dis Child"},{"issue":"Suppl168","key":"1947_CR13","first-page":"1","volume":"138","author":"C Rudin","year":"2008","unstructured":"Rudin C, Boubaker K, Raeber PA, et al: Toxoplasmosis during pregnancy and infancy. A new approach for Switzerland. Swiss Med Wkly. 2008, 138 (Suppl168): 1-8. [cited 2010 Aug 7. http:\/\/www.smw.ch\/docs\/PdfContent\/smw-12781.pdf]","journal-title":"Swiss Med Wkly"},{"key":"1947_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0140-6736(07)60403-6","volume":"369","author":"P Martinelli","year":"2007","unstructured":"Martinelli P, Agangi A, Maruotti G: Screening for toxoplasmosis in pregnancy. Lancet. 2007, 369: 823-824.","journal-title":"Lancet"},{"key":"1947_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1590\/S0074-02762009000200026","volume":"104","author":"R Gilbert","year":"2009","unstructured":"Gilbert R: Treatment for congenital toxoplasmosis: finding out what works. Mem Inst Oswaldo Cruz. 2009, 104: 305-311. 10.1590\/S0074-02762009000200026.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1947_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/INF.0b013e318134286d","volume":"27","author":"F Kieffer","year":"2008","unstructured":"Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J: Risk factors for retinochorioiditis during the first 2\u2009years of life in infants with treated toxoplasmosis. Pediatr Infect Dis J. 2008, 27: 27-32. 10.1097\/INF.0b013e318134286d.","journal-title":"Pediatr Infect Dis J"},{"key":"1947_CR17","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/590149","volume":"47","author":"JG Montoya","year":"2008","unstructured":"Montoya JG, Remington JS: Management of Toxoplasma gondii Infectionduring Pregnancy. Clin Infect Dis. 2008, 47: 554-566. 10.1086\/590149.","journal-title":"Clin Infect Dis"},{"key":"1947_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1590\/S0074-02762009000200029","volume":"104","author":"R Mc Leod","year":"2009","unstructured":"Mc Leod R, Kieffer F, Sautter M, Hosten T, Pelloux H: Why prevent, diagnose and treat congenital toxoplasmosis?. Mem Inst Oswaldo Cruz. 2009, 104: 320-344. 10.1590\/S0074-02762009000200029.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1947_CR19","doi-asserted-by":"publisher","first-page":"e1000351","DOI":"10.1371\/journal.pmed.1000351","volume":"7","author":"M Cortina-Borja","year":"2010","unstructured":"Cortina-Borja M, Tan HK, Wallon M, et al: Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 2010, 7: e1000351-10.1371\/journal.pmed.1000351. [cited 2011 Sep 30. http:\/\/www.plosmedicine.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pmed.1000351]","journal-title":"PLoS Med"},{"key":"1947_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejogrb.2005.07.019","volume":"124","author":"R Thi\u00e9baut","year":"2006","unstructured":"Thi\u00e9baut R, Leroy V, Alioum A, et al: Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis. Eur J Obstet Gynecol. 2006, 124: 3-9. 10.1016\/j.ejogrb.2005.07.019.","journal-title":"Eur J Obstet Gynecol"},{"key":"1947_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/1471-2334-11-348","volume":"11","author":"U Sagel","year":"2011","unstructured":"Sagel U, Kr\u00e4mer A, Mikolajczyk RT: Incidence of maternal Toxoplasma infection in pregnancy in Upper Austria, 2000\u20132007. BMC Infect Dis. 2011, 11: 348-10.1186\/1471-2334-11-348. [cited 2012 May 4. http:\/\/www.biomedcentral.com\/1471-2334\/11\/348]","journal-title":"BMC Infect Dis"},{"issue":"9","key":"1947_CR22","doi-asserted-by":"crossref","first-page":"pii=19137","DOI":"10.2807\/ese.14.09.19137-en","volume":"14","author":"C Cornu","year":"2009","unstructured":"Cornu C, Bissery A, Malbos C, Garwig R, Cocherel C, Ecochard R, et al: Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France. Eurosurveill. 2009, 14 (9): pii=19137-[2010 Aug 7 http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19137]","journal-title":"Eurosurveill"},{"key":"1947_CR23","first-page":"112","volume":"2","author":"M De Paschale","year":"2010","unstructured":"De Paschale M, Agrappi C, Manco MT, Cerulli T, Clerici P: Implementation of Screening for Toxoplasma gondii in Pregnancy. J Clin Med Research. 2010, 2: 112-116.","journal-title":"J Clin Med Research"},{"key":"1947_CR24","first-page":"27","volume":"19","author":"EG Lago","year":"2009","unstructured":"Lago EG, Carvalho RL, Jungblut R, et al: Screening for Toxoplasma gondii antibodies in 2,513 consecutive parturient women and evaluation of newborn infants at risk for congenital toxoplasmosis. Sci Med. 2009, 19: 27-34. [cited 2011 Sep 27. http:\/\/www.revistaseletronicas.pucrs.br\/ojs\/index.php\/scientiamedica\/article\/view\/5004\/5074]","journal-title":"Sci Med"},{"key":"1947_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1469-0691.2006.01444.x","volume":"12","author":"A Sensini","year":"2006","unstructured":"Sensini A: Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clin Microbiol Infect. 2006, 12: 504-512. 10.1111\/j.1469-0691.2006.01444.x.","journal-title":"Clin Microbiol Infect"},{"key":"1947_CR26","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(98)08220-8","volume":"353","author":"D Dunn","year":"1999","unstructured":"Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R: Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet. 1999, 353: 1829-1833. 10.1016\/S0140-6736(98)08220-8.","journal-title":"Lancet"},{"key":"1947_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1590\/S0074-02762009000200025","volume":"104","author":"G Ch\u00eane","year":"2009","unstructured":"Ch\u00eane G, Thi\u00e9baut R: Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis. Mem Inst Oswaldo Cruz. 2009, 104: 299-304. 10.1590\/S0074-02762009000200025.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1947_CR28","first-page":"41","volume":"29","author":"AR Prusa","year":"2005","unstructured":"Prusa AR, Hayde M, Gerstl N, Pollak A: Infection with Toxoplasma gondii during pregnancy [German]. Gyn\u00e4kologische Praxis. 2005, 29: 41-44.","journal-title":"Gyn\u00e4kologische Praxis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-118\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:45:52Z","timestamp":1630525552000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,16]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1947"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-118","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,16]]},"assertion":[{"value":"6 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"118"}}